Column 13. Comments on RAI Therapy Including the Actual Situation in Japan

  • Seigo Kinuya
  • Naoyuki Shigematsu
  • Yasushi Noguchi
  • Tatsuya Higashi


In Japan, the number of patients who undergo RAI therapy has been increasing annually, and the demand is increasing. However, the reality is that the number of operational beds has decreased. Thus, it is impossible to aggressively perform ablation after total thyroidectomy and the waiting time for RAI therapy is prolonged. However, the situation for RAI therapy is expected to improve with the availability of ablation using up to 30 mCi of RAI at outpatient clinics, which is soon to be approved.


Total Thyroidectomy Differentiate Thyroid Carcinoma Serum Thyroglobulin Remnant Thyroid Carcinoma Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428 (RS)PubMedCrossRefGoogle Scholar
  2. 2.
    Mazzaferri EL, Kloos RT (2001) Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463 (NR)PubMedCrossRefGoogle Scholar
  3. 3.
    Robbins RJ, Schlumberger MJ (2005) The evolving role of 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med 46(Suppl 1):28S–37S (NR)PubMedGoogle Scholar
  4. 4.
    Sawka AM, Thephamongkhol K, Brouwers M et al (2004) Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89:3668–3676 (SR<RS>)PubMedCrossRefGoogle Scholar
  5. 5.
    Yokoyama K, Kinutani K, Michigishi T et al (2006) (Text in Japanese) Geka 68:773–776 (NR)Google Scholar
  6. 6.
    Shibuya H, Sugino K, Nagahama M et al (2007) (Text in Japanese) Rinsho Hoshasen 52:847–854 (RS)Google Scholar
  7. 7.
    Kusakabe K (2006) (Text in Japanese) Horumon to Rinsho 54:113–116 (NR)Google Scholar
  8. 8.
    Hackshaw A, Harmer C, Mallick U et al (2007) 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin Endocrinol Metab 92:28–38 (SR<RS>)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Seigo Kinuya
    • 1
  • Naoyuki Shigematsu
    • 2
  • Yasushi Noguchi
    • 3
  • Tatsuya Higashi
    • 4
  1. 1.Department of Nuclear Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health ScienceKanazawa UniversityKanazawaJapan
  2. 2.Department of RadiologyKeio University School of MedicineTokyoJapan
  3. 3.Department of RadiologyNoguchi Thyroid Clinic and Hospital FoundationBeppuJapan
  4. 4.Shiga Medical Center Research InstituteOtsu-shiJapan

Personalised recommendations